Cargando…
Access to device-aided therapies in advanced Parkinson’s disease: navigating clinician biases, patient preference, and prognostic uncertainty
Device-aided therapies (DAT), which include deep brain stimulation and pump-based continuous dopaminergic stimulation with either levodopa or apomorphine, are among the major advances in the clinical management of Parkinson’s disease (PD). Although DAT are being increasingly offered earlier in the d...
Autores principales: | Auffret, Manon, Weiss, Daniel, Stocchi, Fabrizio, Vérin, Marc, Jost, Wolfgang H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645670/ https://www.ncbi.nlm.nih.gov/pubmed/37436446 http://dx.doi.org/10.1007/s00702-023-02668-9 |
Ejemplares similares
-
Adopting the Rumsfeld approach to understanding the action of levodopa and apomorphine in Parkinson’s disease
por: Jenner, P., et al.
Publicado: (2023) -
Optimised endoscopic access for intrajejunal levodopa application in idiopathic Parkinson's syndrome
por: Grund, K. E., et al.
Publicado: (2023) -
Clinicians' preferences for managing aneurysmal subarachnoid hemorrhage using endothelin receptor antagonists
por: Heidenreich, Sebastian, et al.
Publicado: (2023) -
Feasibility and benefits of home initiation of subcutaneous apomorphine infusion for patients with Parkinson’s disease: the APOKADO study
por: Zagnoli, Fabien, et al.
Publicado: (2023) -
Parkinson’s disease between internal medicine and neurology
por: Csoti, Ilona, et al.
Publicado: (2015)